BioPhorum Operations Group Invites Industry Stakeholders to Participate in Technology Roadmap

Article

The group is inviting additional industry stakeholders to participate in the technology roadmapping process to address complexity of the current industry structure, which the group says has held back innovation.

The BioPhorum Operations Group is inviting industry stakeholders including academics, supply partner R&D heads, regulators, and regional hubs to participate in the group’s Technology Roadmap for the future of biopharmaceuticals. The Technology Roadmap is being developed in response to the complexity of the current industry structure, which the group says has held back innovation with many end users trying to develop new technologies in isolation, and resulting in suppliers having to guess end user requirements. The group currently has more than 100 active participants in the roadmapping process, consisting of a steering committee and six teams working to address key technology challenges.

Eighteen BioPhorum member companies are currently developing the roadmap, and the group is hoping to add additional participants to the project. When complete, the Technology Roadmap will be available for free and updated and published on a regular basis. 

Source: BioPhorum Operations Group

Recent Videos
Simon Wright from Almac Pharma Services chats about shifting demand for commercial manufacturing services and how service providers are adapting to meet demand.
Ian Lafferty from Upperton discusses the trends and challenges facing sterile manufacturing and how partnering with CDMOs can help innovators progress to the market.
Industry Outlook 2025: The Rising Prominence of AI in Pharma
Adam Sherlock, CEO of Qinecsa, discusses the changing political landscapes in the US and Europe and how that may affect the bio/pharma industry.
Adam Sherlock, CEO of Qinecsa Solutions
Related Content
© 2025 MJH Life Sciences

All rights reserved.